BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS




Industry
Services

Segment
Publisher





 Company News
Amgen (AMGN) Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha (evolocumab) In The The New England Journal of Medicine 3/16/2015 6:40:58 AM
Sanofi (SAN.PA), Regeneron (REGN): 18-Month Results Of ODYSSEY LONG TERM Trial With Praluent (Alirocumab) Published In The New England Journal of Medicine 3/16/2015 6:01:28 AM
The New England Journal of Medicine Publishes Positive Results From Clinical Study Of Neovasc Inc. (NVC)'s Reducer Product 2/5/2015 8:32:37 AM
Stryker Release: Study Published In The New England Journal of Medicine Finds Intra-Arterial Treatment For Clot Removal Is More Effective At Treating Stroke Than Standard Medical Care 12/17/2014 9:25:38 AM
Phase 3 Results Published In The New England Journal of Medicine Show Superiority Of Pfizer (PFE)’s XALKORI® (crizotinib) Compared To Platinum-Based Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer 12/4/2014 10:12:52 AM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-APOCIII Rx Phase 2 Study In Patients With Familial Chylomicronemia Published In The New England Journal of Medicine 12/4/2014 7:16:46 AM
ZS Pharma (ZSPH) Announces Publication Of Results From Phase 3 Study Of ZS-9 In Patients With Hyperkalemia In The New England Journal of Medicine 11/21/2014 11:21:28 AM
Relypsa, Inc. (RLYP) Announces Data Published In The New England Journal of Medicine For Pivotal Phase 3 Program Of Patiromer FOS For The Treatment Of Hyperkalemia 11/21/2014 11:20:05 AM
Perosphere Inc.’s Anticoagulant Reversal Agent Clinical Trial Results Published In The New England Journal of Medicine 11/6/2014 10:35:02 AM
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals 8/7/2014 7:41:19 AM
12345678910...